PDCD2 Sensitizes HepG2 Cells to Sorafenib by Suppressing Epithelial‑mesenchymal Transition
Molecular Medicine Reports - Greece
doi 10.3892/mmr.2019.9860
Full Text
Open PDFAbstract
Available in full text
Date
January 15, 2019
Authors
Publisher
Spandidos Publications